Description: Open source programming languages have become a common part of the actuarial toolkit over the years. Using tools like R and Python, highly technical actuaries can automate onerous processes, easily work with massive amounts of data, create models and generate reports. Although these tools excel at turbo-charging analysts, it can be difficult for benefits to inure to the rest of the organization given the learning curve (“Can’t you just put this in Excel?”), control risks (“So your entire process could break overnight if some random person in Nebraska changes something?”), and internal IT environments. Listen in on a panel discussion where presenters share their personal stories of working with open source in a production setting. Hear about real world business problems, how open source tools were used, what risks were present, how they were overcome and the final business result.

Description: Come discuss how to treat experience that is impacted by COVID (e.g., 2020+), as well as expected experience moving forward in terms of excess deaths related to COVID and non-COVID topics. Expect to also cover how the COVID period has impacted lapse/surrender behavior and trends in recent industry mortality and lapse studies that have been conducted including areas where individual companies typically have limited data. You will learn about various techniques of adjusting experience for the impact of COVID and the considerations in using such experience and setting a best-estimate assumption going forward. For mortality, the discussion will include both base mortality as well as future mortality improvement and the intersection of both of these.Explore an understanding of available data to supplement their experience in areas where they may have limited internal experience

Description: Discuss issues related to illustrations, including illustration testing, ASOP 24, the illustration model regulation and AG 49 at the practice level. Come prepared with questions and comments on the world of illustrations and illustration testing. Explore ideas for what's working and not working in the illustration world and formulate plans to tackle pressing illustrations issues. At the end of this workshop, you will be able to Identify issues related to illustrations and illustration testing for life products, discuss possible ways to resolve issues issue identified, and explore the future state of illustrations and illustration testing for various products.

Description: 2022 was a year of radical change for the annuity market as interest rates increased from historic lows. The rapid growth of RILA products stalled as FIA and MYGA products saw a significant increase in market share. The impacts of the higher rate environment are continuing to be realized in experience, inforce management, product design and more. Explore the retail annuity market with a focus on the impacts of higher interest rates. Expect session materials to draw on experience studies, sales results, product changes, and more which will examine how higher interest rates have altered the annuity market.

Description: Discuss how to treat experience that is impacted by COVID-19 (e.g., 2020+) as well as expected experience moving forward in terms of excess deaths related to COVID and non-COVID topics. The session will also cover how the COVID period has impacted lapse/surrender behavior and the trends that we can expect going forward. Learn about various techniques of adjusting experience for the impact of COVID and the considerations in using such experience and setting a best-estimate assumption going forward. For mortality, the discussion will include both base mortality as well as future mortality improvement and the intersection of both of these.

Description: Join us as we explore how recent innovations & future changes in the American worksite will impact the future of the Critical Illness product

Description: An interview with Weili Lu, the president of ARIA

Description: The world of climate risk disclosures has seen dizzying levels of change in the last few years. In 2023, many regulators have publicly issued guidance on what insurance companies and other FIs should look to disclose. So what are we seeing in these disclosures and how do we use this information? Join our panel of experts to learn about the evolution of U.S. life insurance industry's climate disclosures and how insurers of all sizes and complexities are responding to NAIC's requirements.

Description: Discuss population mortality improvement trends in the U.S. This will include analysis of cause of death data and trends in mortality pre-pandemic and during the pandemic. We will also discuss ways to think about translating population mortality improvement to an insured population.Learning outcomes includea better understanding of the drivers of recent mortality improvement and insights on how to create a company view on mortality improvement.

Description: The document is about the post-wildfire drinking water crisis and its implications for the insurance industry. It discusses the contamination of drinking water systems by wildfires, remediation strategies, financial considerations for the insurance industry, and potential contributions from the actuarial community.